(Q39067604)

8 September 2017

title

Immune resolution mechanisms in inflammatory arthritis (English)

1 reference

8 September 2017

0 references

Lucy V Norling

4

0 references

Mauro Perretti

series ordinal

1

object named as

Mauro Perretti

1 reference

8 September 2017

Dianne Cooper

2

1 reference

8 September 2017

Jesmond Dalli

series ordinal

3

1 reference

8 September 2017

language of work or name

English

0 references

publication date

5 January 2017

1 reference

Nature Reviews Rheumatology

8 September 2017

published in

1 reference

8 September 2017

volume

13

1 reference

8 September 2017

issue

2

1 reference

8 September 2017

page(s)

87-99

1 reference

Pro-resolving lipid mediators are leads for resolution physiology

8 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Identification and Actions of a Novel Third Maresin Conjugate in Tissue Regeneration: MCTR3

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Origin and physiological roles of inflammation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Leukocyte migration into inflamed tissues.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Heme oxygenase: a novel target for the modulation of the inflammatory response

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Inducible cyclooxygenase may have anti-inflammatory properties

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Lipoxins, aspirin-triggered epi-lipoxins, lipoxin stable analogues, and the resolution of inflammation: stimulation of macrophage phagocytosis of apoptotic neutrophils in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Resolvin E1 promotes phagocytosis-induced neutrophil apoptosis and accelerates resolution of pulmonary inflammation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

The resolution code of acute inflammation: Novel pro-resolving lipid mediators in resolution

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Proresolving lipid mediators and mechanisms in the resolution of acute inflammation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Resolution of inflammation: an integrated view

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

New insights into the resolution of inflammation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Sulphasalazine accelerates apoptosis in neutrophils exposed to immune complex: Role of caspase pathway.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Cyclin-dependent kinase inhibitors enhance the resolution of inflammation by promoting inflammatory cell apoptosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Molecular circuits of resolution: formation and actions of resolvins and protectins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Spatial and temporal profiles for anti-inflammatory gene expression in leukocytes during a resolving model of peritonitis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Lipoxins: novel series of biologically active compounds formed from arachidonic acid in human leukocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Lipoxin synthase activity of human platelet 12-lipoxygenase

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Mediator-lipidomics: databases and search algorithms for PUFA-derived mediators

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Specific lipid mediator signatures of human phagocytes: microparticles stimulate macrophage efferocytosis and pro-resolving mediators

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Identification and signature profiles for pro-resolving and inflammatory lipid mediators in human tissue

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Human milk proresolving mediators stimulate resolution of acute inflammation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Determination of ω-6 and ω-3 PUFA metabolites in human urine samples using UPLC/MS/MS.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Divergent shifts in lipid mediator profile following supplementation with n-3 docosapentaenoic acid and eicosapentaenoic acid

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

High levels of anti-inflammatory and pro-resolving lipid mediators lipoxins and resolvins and declining docosahexaenoic acid levels in human milk during the first month of lactation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Specialised pro-resolving mediators of inflammation in inflammatory arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Maternal dietary omega-3 fatty acid intake increases resolvin and protectin levels in the rat placenta

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

The lipid mediator protectin D1 inhibits influenza virus replication and improves severe influenza

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Influence of marine n-3 polyunsaturated fatty acids on immune function and a systematic review of their effects on clinical outcomes in rheumatoid arthritis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

12/15-lipoxygenase counteracts inflammation and tissue damage in arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Anti-inflammatory role of the murine formyl-peptide receptor 2: ligand-specific effects on leukocyte responses and experimental inflammation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

5-Lipoxygenase-deficient mice infected with Borrelia burgdorferi develop persistent arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Resolution of inflammation in murine autoimmune arthritis is disrupted by cyclooxygenase-2 inhibition and restored by prostaglandin E2-mediated lipoxin A4 production

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Expression of 5-lipoxygenase and 15-lipoxygenase in rheumatoid arthritis synovium and effects of intraarticular glucocorticoids

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Human articular chondrocytes express 15-lipoxygenase-1 and -2: potential role in osteoarthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Proresolving and cartilage-protective actions of resolvin D1 in inflammatory arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Lipid and lipid mediator profiling of human synovial fluid in rheumatoid arthritis patients by means of LC-MS/MS

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

The precursor of resolvin D series and aspirin-triggered resolvin D1 display anti-hyperalgesic properties in adjuvant-induced arthritis in rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Adenosine as a Multi-Signalling Guardian Angel in Human Diseases: When, Where and How Does it Exert its Protective Effects?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Methotrexate--how does it really work?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Low expression of CD39 on regulatory T cells as a biomarker for resistance to methotrexate therapy in rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Cytokines as therapeutic targets in rheumatoid arthritis and other inflammatory diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Control of myeloid cell trafficking in resolution.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Selective activation of adenosine A2A receptors on immune cells by a CD73-dependent prodrug suppresses joint inflammation in experimental rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Adenosine A2A receptor activation prevents wear particle-induced osteolysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Gaseous mediators in resolution of inflammation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Antiinflammatory activity of soluble guanylate cyclase: cGMP-dependent down-regulation of P-selectin expression and leukocyte recruitment.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Hydrogen sulfide is an endogenous modulator of leukocyte-mediated inflammation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Annexin A1 mediates hydrogen sulfide properties in the control of inflammation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

H2S transiently blocks IL-6 expression in rheumatoid arthritic fibroblast-like synoviocytes and deactivates p44/42 mitogen-activated protein kinase

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Effect of hydrogen sulfide sources on inflammation and catabolic markers on interleukin 1β-stimulated human articular chondrocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Inhaled carbon monoxide accelerates resolution of inflammation via unique proresolving mediator-heme oxygenase-1 circuits

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Cell-cell interactions and bronchoconstrictor eicosanoid reduction with inhaled carbon monoxide and resolvin D1.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

ACTH as a treatment for acute crystal-induced arthritis: update on clinical evidence and mechanisms of action

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Effects of adrenocorticotropic hormone (ACTH) in gout

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

ACTH: The forgotten therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Role of proopiomelanocortin-derived peptides and their receptors in the osteoarticular system: from basic to translational research

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Activation of melanocortin type 3 receptor as a molecular mechanism for adrenocorticotropic hormone efficacy in gouty arthritis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Association between periodontal disease and inflammatory arthritis reveals modulatory functions by melanocortin receptor type 3.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Anti-inflammatory and antiosteoclastogenesis properties of endogenous melanocortin receptor type 3 in experimental arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

The melanocortin system in articular chondrocytes: melanocortin receptors, pro-opiomelanocortin, precursor proteases, and a regulatory effect of alpha-melanocyte-stimulating hormone on proinflammatory cytokines and extracellular matrix components.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Melanocortin peptides protect chondrocytes from mechanically induced cartilage injury

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Spatial and temporal localization of the melanocortin 1 receptor and its ligand α-melanocyte-stimulating hormone during cutaneous wound repair

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Annexin A1 and glucocorticoids as effectors of the resolution of inflammation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Annexin A1 counteracts chemokine-induced arterial myeloid cell recruitment.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Gene expression signature-based approach identifies a pro-resolving mechanism of action for histone deacetylase inhibitors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Endogenous annexin A1 is a novel protective determinant in nonalcoholic steatohepatitis in mice.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Targeted nanoparticles containing the proresolving peptide Ac2-26 protect against advanced atherosclerosis in hypercholesterolemic mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Modulation of inflammation and response to dexamethasone by Annexin 1 in antigen-induced arthritis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

The impact of endogenous annexin A1 on glucocorticoid control of inflammatory arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Endogenous galectin-1 and acute inflammation: emerging notion of a galectin-9 pro-resolving effect.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Tolerogenic signals delivered by dendritic cells to T cells through a galectin-1-driven immunoregulatory circuit involving interleukin 27 and interleukin 10.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Anesthetics impact the resolution of inflammation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Galectin-1 regulates tissue exit of specific dendritic cell populations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Galectin 3 aggravates joint inflammation and destruction in antigen-induced arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Galectin-9 ameliorates immune complex-induced arthritis by regulating Fc gamma R expression on macrophages.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Recombinant galectin-1 and its genetic delivery suppress collagen-induced arthritis via T cell apoptosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Endogenous galectin-1 exerts tonic inhibition on experimental arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Beneficial effect of galectin 9 on rheumatoid arthritis by induction of apoptosis of synovial fibroblasts

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Galectin-9 suppresses the generation of Th17, promotes the induction of regulatory T cells, and regulates experimental autoimmune arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

The role of stromal cells in the persistence of chronic inflammation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

A decrease in galectin-1 (Gal-1) levels correlates with an increase in anti-Gal-1 antibodies at the synovial level in patients with rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Galectin-8 and galectin-9 are novel substrates for thrombin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Overcoming hurdles in developing successful drugs targeting chemokine receptors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Chemokine blockers--therapeutics in the making?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

A vasculo-protective circuit centered on lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 operative in murine microcirculation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Maresin 1 biosynthesis during platelet-neutrophil interactions is organ-protective

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

The required role of endogenously produced lipoxin A4 and annexin-1 for the production of IL-10 and inflammatory hyporesponsiveness in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Infection regulates pro-resolving mediators that lower antibiotic requirements

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Evidence for an anti-inflammatory loop centered on polymorphonuclear leukocyte formyl peptide receptor 2/lipoxin A4 receptor and operative in the inflamed microvasculature

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

A2A and A3 adenosine receptor expression in rheumatoid arthritis: upregulation, inverse correlation with disease activity score and suppression of inflammatory cytokine and metalloproteinase release

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Resolution Pharmacology: Opportunities for Therapeutic Innovation in Inflammation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Methotrexate and sulfasalazine promote adenosine release by a mechanism that requires ecto-5'-nucleotidase-mediated conversion of adenine nucleotides

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Proresolving Actions of Synthetic and Natural Protease Inhibitors Are Mediated by Annexin A1.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Connections in pharmacology: innovation serving translational medicine

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Alpha-1-anti-trypsin-Fc fusion protein ameliorates gouty arthritis by reducing release and extracellular processing of IL-1β and by the induction of endogenous IL-1Ra

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Proresolving actions of a new resolvin D1 analog mimetic qualifies as an immunoresolvent

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Molecular engineering of short half-life small peptides (VIP, αMSH and γ₃MSH) fused to latency-associated peptide results in improved anti-inflammatory therapeutics

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Ligand-specific conformational change of the G-protein-coupled receptor ALX/FPR2 determines proresolving functional responses.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Serum amyloid A opposes lipoxin A₄ to mediate glucocorticoid refractory lung inflammation in chronic obstructive pulmonary disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Biased agonism as a novel strategy to harness the proresolving properties of melanocortin receptors without eliciting melanogenic effects.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Biological properties of extracellular vesicles and their physiological functions.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Annexin 1 mediates the rapid anti-inflammatory effects of neutrophil-derived microparticles

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Activated polymorphonuclear neutrophils disseminate anti-inflammatory microparticles by ectocytosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Cutting edge: Humanized nano-proresolving medicines mimic inflammation-resolution and enhance wound healing

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Proresolving nanomedicines activate bone regeneration in periodontitis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Neutrophil-derived microvesicles enter cartilage and protect the joint in inflammatory arthritis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Annexin A1-containing extracellular vesicles and polymeric nanoparticles promote epithelial wound repair.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Elucidation of novel 13-series resolvins that increase with atorvastatin and clear infections

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Resolvin Infectious Inflammation by Targeting the Host Response

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Hydrogen sulfide-based therapeutics: exploiting a unique but ubiquitous gasotransmitter

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Changes in lipid levels with inflammation and therapy in RA: a maturing paradigm

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Comparison of lipid and lipid-associated cardiovascular risk marker changes after treatment with tocilizumab or adalimumab in patients with rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Microparticle alpha-2-macroglobulin enhances pro-resolving responses and promotes survival in sepsis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Human Sepsis Eicosanoid and Proresolving Lipid Mediator Temporal Profiles: Correlations With Survival and Clinical Outcomes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Investigational analysis reveals a potential role for neutrophils in giant-cell arteritis disease progression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Annexin-1 modulates T-cell activation and differentiation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Resolution of acute inflammation bridges the gap between innate and adaptive immunity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Inhibitory control of endothelial galectin-1 on in vitro and in vivo lymphocyte trafficking

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Endothelial cell expression of galectin-1 induced by prostate cancer cells inhibits T-cell transendothelial migration

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Novel insights into the inhibitory effects of Galectin-1 on neutrophil recruitment under flow

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Dimeric galectin-1 induces surface exposure of phosphatidylserine and phagocytic recognition of leukocytes without inducing apoptosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Development of a Nascent Galectin-1 Chimeric Molecule for Studying the Role of Leukocyte Galectin-1 Ligands and Immune Disease Modulation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Apoptosis of T cells mediated by galectin-1.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Galectin-1 induces 12/15-lipoxygenase expression in murine macrophages and favors their conversion toward a pro-resolving phenotype

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Regulatory T-cells in systemic lupus erythematosus and rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Galectin-1: a key effector of regulation mediated by CD4+CD25+ T cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Galectin-9-CD44 interaction enhances stability and function of adaptive regulatory T cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Augmentation of myocardial production of 15-epi-lipoxin-a4 by pioglitazone and atorvastatin in the rat

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Simvastatin and Benznidazole-Mediated Prevention of Trypanosoma cruzi-Induced Endothelial Activation: Role of 15-epi-lipoxin A4 in the Action of Simvastatin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Lovastatin decreases acute mucosal inflammation via 15-epi-lipoxin A4.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.193

Inflammation and infection: historic highlights.

31 March 2020

1 reference

12 December 2020

Antiinflammatory mediator lipoxin A4 and its receptor in synovitis of patients with rheumatoid arthritis

1 reference

12 December 2020

Hydrogen sulfide releasing naproxen offers better anti-inflammatory and chondroprotective effect relative to naproxen in a rat model of zymosan induced arthritis.

1 reference

12 December 2020

Expression of galectins-1 and -3 correlates with defective mononuclear cell apoptosis in patients with juvenile idiopathic arthritis

1 reference

12 December 2020

Endogenous mediators that inhibit the leukocyte-endothelium interaction

1 reference

12 December 2020

How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions

1 reference

12 December 2020

The effect of a hormone of the adrenal cortex (17-hydroxy-11-dehydrocorticosterone; compound E) and of pituitary adrenocorticotropic hormone on rheumatoid arthritis

1 reference

12 December 2020

Glucocorticoids promote nonphlogistic phagocytosis of apoptotic leukocytes

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRRHEUM.2016.193

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/rrp4qcbmefdr5dzvkuo4pnetwm

30 July 2022

mapped directly with Wikidata item

Fatcat ID

release_rrp4qcbmefdr5dzvkuo4pnetwm

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/rrp4qcbmefdr5dzvkuo4pnetwm

30 July 2022

mapped directly with Wikidata item

https://api.fatcat.wiki/v0/release/rrp4qcbmefdr5dzvkuo4pnetwm

1 reference

30 July 2022